Hemosiderosis is a rare, often fatal, condition in which iron builds up in the lungs. The iron is in the form of hemosiderin, a pigment in blood. Hemosiderosis results from bleeding into the lungs, also known as pulmonary hemorrhage.
Pulmonary hemosiderosis is often broken down into four categories:
This condition usually shows up between the ages of 6 months and 20 years. Blood that leaks out of the capillaries is taken up by scavenger cells in the lung. The breakdown products of the blood irritate the lung and lead to scarring.
Hemosiderosis is often linked with anemia and chronic infections. It may also be caused by problems with the heart or the immune system.
Pulmonary hemosiderosis is more common in children under 10 years old. It is equally common in boys and girls. When it begins in adulthood, it is more likely to affect males.
Symptoms include:
Diagnosis begins with a medical history and physical exam. Diagnostic tests may include:
The diagnosis is often made by ruling out other causes of bleeding into the lungs.
Prevention is based on treating the underlying cause. If another condition causes bleeding into the lungs, hemosiderosis can develop.
If hemosiderosis is not effectively treated, long-term effects from the bleeding and kidney damage can include:
Hemosiderosis is not contagious. If the underlying cause is an infection, that infection may be contagious.
The treatment depends on the cause. Blood transfusions may be needed for blood loss. Supplemental oxygen is given for low levels of oxygen in the blood. Corticosteroids and medications that suppress the immune system are often used. If the cause is sensitivity to cow's milk, a milk-free diet may be recommended.
Side effects depend on the treatment used. Side effects of steroids may include stomach upset, jittery feelings, muscle weakness, bloating, and weight gain.
Pulmonary bleeding can recur from time to time and will need to be evaluated.
This condition is monitored for the rest of the person's life. Any further bleeding in the lungs must be evaluated. The healthcare provider should be told about any new or worsening symptoms. Blood tests, pulmonary function tests, and chest x-rays may also help monitor the course of the disease.
Author:Eileen McLaughlin, RN, BSN
Date Written:
Editor:Duff, Ellen, BA
Edit Date:09/08/00
Reviewer:Gail Hendrickson, RN, BS
Date Reviewed:07/02/01
www.cdc.gov/genetics/publications/h_hemo.html
Current Pediatric Diagnosis and Treatment, Hathaway, Groothuis, Hay, Paisley, 1993.
Illustrated Guide to Diagnostic Tests, Springhouse, 1998.
Harrison's Principles of Internal Medicine, Fauci, 1998.